06.10.2012 • NewsUnivarchemical industrychemicals

Univar, Tate & Lyle SugarsAnnounce Pan-European Distribution Agreement

Univar, a global chemical distributor, announced today it has entered into an agreement with Tate & Lyle Sugars, who are part of the same group as Domino Foods, to distribute a range of value-added functional ingredients across Europe.

Univar will market and sell Domino's ranges of granular and powdered Qwik-Flo co-crystalised molasses and Dri-Flo molasses, its granular and powdered Qwik-Flo co-crystalised honey and Dri- Flo HonyBuds, and its sugar-based flavour and texture modifier Super Envision. These highperformance and innovative ingredients have applications across the food sector including bakery, confectionary, ready meals, soups and sauces.

Domino's dry granular and powdered molasses are used as natural sweeteners that can act as substitutes for highly refined sugar and non-nutritive syrups. The honey products are used to impart a distinct flavour to food as well as increase moisture retention and enhance shelf-life. Domino's flavor and texture modifiers use patented co-crystallised technology to produce sugar based ingredients that allow manufacturers to control the sweetness of finished products as well as enhance texture, structure and dispersion.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.